biology2 papersavg year 2026quality 5/5strong evidence

Safety and Off-target Effects

Research gap analysis derived from 2 biology papers in our local library.

The gap

Systematic evaluation of adverse effects and off-target toxicity is needed for therapeutic approaches targeting RNF20, CD24, lncRNA-LNP delivery systems, CCHF antiviral drugs, and stress granule modulators in clinical settings.

Consensus across the literature

Papers collectively establish the need for comprehensive safety assessments but leave open specific methodologies and populations to be studied.

Research trend

Emerging — attention growing, methods still coalescing.

Supporting evidence — 2 representative gaps

  • Decoding RNF20: an epigenetic modifier and beyond (2026) · doi

    Side effects and off-target toxicities of drugs targeting RNF20 require more in-depth exploration and adequate validation. Systematic characterization of adverse effects in normal tissues and organ systems is needed to establish the clinical safety profile of RNF20-targeting therapeutics.

    Keywords: RNF20 targeting side-effects off-target toxicity drug safety clinical validation organ toxicity
  • CD24 as an innate immune checkpoint in solid tumors: biology, biomarker stratification, and therapeutic translation (2026) · doi

    Safety profiles and potential off-target effects of CD24-targeting approaches in clinical settings need comprehensive characterization

    Keywords: safety profiles potential target effects targeting approaches clinical settings need comprehensive characterization

Working on this gap? Publish with us.

Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.

Related gaps in biology

Command palette

Jump anywhere, run any action.